Maraviroc
-
Catalog numberB2044-25
-
PricePlease ask
-
Size25 mg
-
-
Alternative_name4,4-difluoro-N-[(1S)-3-[(3-exo)-3-[3-methyl-5-(1-methylethyl)-4H-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]oct-8-yl]-1-phenylpropyl]-cyclohexanecarboxamide; UK427857; MVC
-
DescriptionMaraviroc is a potent and selective C-C chemokine receptor type 5 (CCR5) antagonist drug that is designed to act against HIV by interfering with the interaction between HIV and CCR5.
-
CAS Number376348-65-1
-
Structure AvailableYes
-
Salt FormNo
-
Molecular FormulaC₂₉H₄₁F₂N₅O
-
Molecular Weight513.67
-
Cell PermeableYes
-
Purity≥98% by HPLC
-
SolubilitiesDMSO (>30 mg/ml)
-
HandlingProtect from air and light
-
Tag LineA potent and selective C-C chemokine receptor type 5 (CCR5) antagonist
-
Storage Condition-20°C
-
Shipping Conditiongel pack
-
Shelf Life36 months
-
MDL NumberMFCD13188530
-
PubChem CID3002977
-
SMILESCC1=NN=C(N1C2CC3CCC(C2)N3CCC(C4=CC=CC=C4)NC(=O)C5CCC(CC5)(F)F)C(C)C
-
InChiInChI=1S/C29H41F2N5O/c1-19(2)27-34-33-20(3)36(27)25-17-23-9-10-24(18-25)35(23)16-13-26(21-7-5-4-6-8-21)32-28(37)22-11-14-29(30,31)15-12-22/h4-8,19,22-26H,9-18H2,1-3H3,(H,32,37)/t23-,24+,25?,26-/m0/s1
-
InChi KeyGSNHKUDZZFZSJB-HLMSNRGBSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameMaraviroc
-
Alternative nameMaraviroc
-